Perspective Therapeutics Inc (CATX) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Perspective Therapeutics Inc   (NYSEAMER: CATX)


Perspective Therapeutics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Perspective Therapeutics Inc's ROI in the second quarter of 2026?
Perspective Therapeutics Inc recorded a cumulative net loss of $-13 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -4.02%.

Within the Healthcare sector Perspective Therapeutics Inc achieved the highest return on investment. While the total ranking for ROI remained the same, compared to the first quarter of 2026 at no. .

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -4.08 % -13.67 % -14.95 % 10.36 % 55.55 %
Y / Y Net Income Change TTM - - -97.03 % - -
Investment (TTM) in Millions 355 379 238 274 298
Return On Investment (TTM) -4.02 % -2.43 % 0.28 % 4.85 % 3.2 %
CATX's Overall Ranking # # # # #
Seq. Investment Change TTM 4.85 % 5.56 % -6.98 % -6.83 % -5.63 %
Seq. Net Income Change TTM - - -94.6 % 41.06 % 22.66 %
Net Income (TTM) in Millions -13 -7 1 15 10

CATX Company Profile >> Back to CATX Roi Comparisons >> See Annual CATX Return On Investment



Return On Investment CATX's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Perspective Therapeutics Inc's II. Quarter Investments $ 355 Millions CATX's Balance sheet
Perspective Therapeutics Inc's II. Quarter Income $ -27 Millions Quarterly CATX's Income Statement
CATX's Income by Division See CATX's Income by Division


CATX Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Jun 30 2022)
2022		 (Jun 30 2021)
2021
Total Investments in Millions 238 323 82 62 69
Y / Y Investment Growth -26.2 % 292.66 % 32.8 % -9.76 % 863.15 %
Net Income in Millions 1 2 3 -7 -3
Y / Y Net Income Growth -62.18 % -20.9 % - - -
Annual Return On Investment 0.33 % 0.65 % 3.22 % -11.74 % -4.94 %


Annual Roi Comment
In the fiscal year 2025 ROI decreased relative to the previous year to 0.33 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CATX's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CATX's Competitors
Subscribers only: Roi for Perspective Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for CATX's Customers

Other Ratios
CATX's Roa CATX's Inventory Turnover Ratio CATX's Growth Rates CATX's Dividend Statistics
CATX's Profitability Ratios CATX's Asset Turnover Ratio CATX's Dividend Growth
CATX's Roe CATX's Valuation Ratios CATX's Financial Strength Ratios CATX's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-26T06:53:13+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.